Cargando…
Microbial biomarkers for immune checkpoint blockade therapy against cancer
Three major standard treatments, i.e., surgery, chemotherapy, and radiotherapy, were traditionally applied to the treatment of cancer and saved many patients. Meanwhile, clinical studies as well as basic research of immunotherapy are being actively conducted for intractable or advanced malignancies...
Autores principales: | Adachi, Keishi, Tamada, Koji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132931/ https://www.ncbi.nlm.nih.gov/pubmed/30003334 http://dx.doi.org/10.1007/s00535-018-1492-9 |
Ejemplares similares
-
Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacy
por: Adachi, Keishi, et al.
Publicado: (2015) -
Paving the road to make chimeric antigen receptor‐T‐cell therapy effective against solid tumors
por: Adachi, Keishi, et al.
Publicado: (2022) -
Predictive biomarkers for tumor immune checkpoint blockade
por: Tong, Mengting, et al.
Publicado: (2018) -
Immune-Checkpoint Blockade Therapy in Lymphoma
por: Kuzume, Ayumi, et al.
Publicado: (2020) -
Genetic and Epigenetic Biomarkers of Immune Checkpoint Blockade Response
por: Xiao, Qingyang, et al.
Publicado: (2020)